Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;2(1):139-45.
doi: 10.2147/opth.s2128.

Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery

Edward F Hall  1 , Garrett R Scott, David C Musch, David N Zacks
Affiliations
Free PMC article

Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery

Edward F Hall et al. Clin Ophthalmol. 2008 Mar.
Free PMC article

Abstract

Purpose: Controversy exists regarding the use of intravitreal dexamethasone (IVD) as an anti-inflammatory adjunct to intravitreal antibiotics in patients with acute endophthalmitis following cataract surgery. The purpose of this project was to evaluate our experience regarding the effect of adjunctive IVD use on visual outcomes in such patients.

Design: Retrospective, comparative case series.

Study population: Patients treated for acute endophthalmitis following cataract surgery from 1995-2004.

Intervention: In addition to standard intravitreal antibiotic treatment, some patients also received a single adjunctive injection of IVD.

Primary outcome measures: Median visual acuity at last follow-up and percentage of patients achieving a >/=3-line improvement in visual acuity.

Secondary outcome measures: Inflammatory index scoring, including amount of cell and flare, height of hypopyon, and presence of fibrin as a function of time after treatment.

Results: Twenty-six eyes were treated with and 38 eyes without adjunctive IVD. Median presenting visual acuity was Hand Motion in both groups. Median visual acuity at last follow-up measured 20/40 in the IVD group and 20/50 in the No-IVD group (p = 0.75). Seventy-three percent of patients in the IVD group and 82% of patients in the No-IVD group achieved a >/=3-line improvement in visual acuity (p = 0.42). No significant difference was detected between the IVD and No-IVD groups for any of the three measures of inflammation.

Conclusion: The use of IVD did not significantly improve the final median visual acuity, the chance of achieving a >/=3-line improvement in visual acuity, or the amount of intraocular inflammation. Based on these findings, and the possible detrimental effect of IVD on visual outcomes previously reported in the literature, the use of IVD does not appear to be warranted as a routine adjunctive treatment in postoperative endophthalmitis.

Keywords: dexamethasone; endophthalmitis; intravitreal injection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of presenting visual acuities in patients treated with or without intravitreal dexamethasone (IVD). The percentage of patients presenting with HM or better vision was significantly higher in the No-IVD group (p = 0.04).
Figure 2
Figure 2
Distribution of visual acuities at last follow-up in patients treated with or without intravitreal dexamethasone (IVD).
See this image and copyright information in PMC

References

    1. Das T, Jalali S, Gothwal VK, et al. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol. 1999;83:1050–5. - PMC - PubMed
    1. Ermis SS, Cetinkaya Z, Kiyici H, et al. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Curr Eye Res. 2007;32:337–44. - PubMed
    1. [EVSG] Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravitreous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–96. - PubMed
    1. Gan IM, Ugahary LC, van Dissel JT, et al. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefe’s Arch Clin Exp Ophthalmol. 2005a;243:1200–5. - PubMed
    1. Gan IM, Ugahary LC, van Dissel JT, et al. Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2005b;243:1186–9. - PubMed

LinkOut - more resources